Literature DB >> 2086705

Mitogenic stimulation alters the regulation of LDL receptor gene expression in human lymphocytes.

J A Cuthbert1, P E Lipsky.   

Abstract

To address the possibility that influences other than ambient cholesterol concentrations regulate low density lipoprotein (LDL) receptor expression, the effect of mitogenic activation on the levels of LDL receptor mRNA in human lymphocytes was examined. Mitogenic stimulation of freshly isolated human peripheral blood mononuclear cells (PBMC) cultured in medium containing saturating concentrations of LDL resulted in cell cycle entry as evidenced by increased levels of mRNA for the interleukin-2 receptor, and also increased LDL receptor mRNA levels by 9-fold. Whereas LDL receptor gene expression was also induced when resting control PBMC were incubated in lipoprotein-deficient medium, mitogenic activation of PBMC cultured in the absence of LDL stimulated a further 3-fold increase in LDL receptor mRNA levels. The increase in LDL receptor mRNA levels in mitogen-stimulated PBMC was dependent on continued protein synthesis, was not the result of mRNA stabilization, and therefore most likely reflected enhanced gene transcription. It was unlikely that the increase in LDL receptor mRNA levels observed in mitogen-stimulated cells related merely to sterol deprivation since suppression of endogenous cholesterol synthesis with lovastatin increased LDL receptor mRNA only modestly. Moreover, mitogen-stimulated PBMC continued to synthesize cholesteryl esters, a storage form of cholesterol, confirming that they were not functionally deprived of sterols. Although mitogenic stimulation increased LDL receptor mRNA levels in PBMC, regulation by exogenous LDL was observed. Thus, LDL down-regulated LDL receptor gene expression in both control and mitogen-stimulated PBMC. Down-regulation was less effective in the latter; however, LDL down-regulated endogenous sterol synthesis to an equivalent extent in both control and mitogen-stimulated PBMC. By contrast, the oxygenated sterol, 25-hydroxycholesterol, and mevalonate, the precursor of endogenously synthesized sterols, down-regulated LDL receptor mRNA levels comparably in mitogen-stimulated and control PBMC. These data indicate that mitogenic stimulation provides an additional stimulus for LDL receptor gene expression over and above that of ambient sterols and, therefore, suggest that signals transduced during cellular activation play a role in regulation of LDL receptor mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2086705

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Identification of essential nucleotides of the FP1 element responsible for enhancement of low density lipoprotein receptor gene transcription.

Authors:  P Dhawan; R Chang; K D Mehta
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes.

Authors:  J B De Sanctis; I Blanca; H Rivera; N E Bianco
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

3.  Growth modulation of low density lipoprotein receptor sterol sensitivity in cultured human fibroblasts.

Authors:  L Tatidis; S Vitols
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

4.  Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.

Authors:  J L Ellsworth; C Chandrasekaran; A D Cooper
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

5.  CSF-resident CD4+ T-cells display a distinct gene expression profile with relevance to immune surveillance and multiple sclerosis.

Authors:  James Hrastelj; Robert Andrews; Samantha Loveless; Joanne Morgan; Stefan Mark Bishop; Nicholas J Bray; Nigel M Williams; Neil P Robertson
Journal:  Brain Commun       Date:  2021-07-13

6.  Differential Response of B Cells to an Immunogen, a Mitogen and a Chemical Carcinogen in a Mouse Model System

Authors:  Nimisha Saxena; Amar Preet Kaur; Nimai Chand Chandra
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.